We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 73

China redefines the authority of its Food, Drug and Device Regulatory Agency

  • Sidley Austin LLP
  • -
  • China
  • -
  • April 16 2013

The Chinese government recently published the final plan to restructure its food, drug and medical device regulatory agency, now named the China Food

China develops special regulatory pathway for local innovative medical device products

  • Sidley Austin LLP
  • -
  • China
  • -
  • April 2 2013

As a part of its 12th Five-Year Plan, the Chinese government has announced a number of policies intended to encourage local research and development

China develops new rules to simplify medical device re-registration process

  • Sidley Austin LLP
  • -
  • China
  • -
  • April 1 2013

China's newly restructured food and drug regulatory agency, the China Food and Drug Administration ("CFDA"), has published new draft rules to

China restructures its healthcare regulators

  • Sidley Austin LLP
  • -
  • China
  • -
  • March 15 2013

On March 14, 2013, the 12th National People's Congress of China approved the plan to restructure several government authorities, including the State

SFDA 2012 Anual Drug Review Report highlights innovator focus

  • Sidley Austin LLP
  • -
  • China
  • -
  • March 8 2013

On February 28, 2013, the Center for Drug Evaluation of the State Foodand Drug Administration ("CDE"), the key agency reviewing safety andefficacy

New Chinese rules significantly heighten personal data protection requirements

  • Sidley Austin LLP
  • -
  • China
  • -
  • February 27 2013

On December 28, 2012, China's legislative body issued a decision that lays out the basic framework for protection of electronic personal data, which

Global Pricing Newsletter: volume two

  • Sidley Austin LLP
  • -
  • China, Global, United Kingdom, USA
  • -
  • February 27 2013

Pharmaceutical and biologic manufacturers operate in an increasingly global economy where legal developments in one market may have cascading impacts

China amends major regulation on drug distribution

  • Sidley Austin LLP
  • -
  • China
  • -
  • February 25 2013

On January 22, 2013, the Ministry of Health of China published the amended Good Supply Practice for Drugs ("Drug GSP"). Drug GSP is one of the key

PRC Ministry of Health issues measures on centralized procurement of high value medical devices

  • Sidley Austin LLP
  • -
  • China
  • -
  • January 23 2013

On December 17, 2012, the Ministry of Health ("MOH") issued a new regulation that subjects certain high-value medical devices to a centralized

China encourages pharmaceutical companies to timely pursue new GMP certification

  • Sidley Austin LLP
  • -
  • China
  • -
  • January 15 2013

In 2010, China's State Food and Drug Administration ("SFDA") issued a new version of its Good Manufacturing Practice (the "GMP") regulations, which

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy